Summary: Creative Biolabs provides GLP-compliant in vivo test services for anti-ROR1 CAR-T cell therapy in neuroblastoma, lung cancer, breast carcinoma, chronic lymphocytic leukemia and ovarian cancer. ROR1 (receptor tyrosine kinase-like orphan receptor 1) is highly expressed in human cells during early embryonic development and exists in a broad spectrum of cancer cells including neuroblastoma, lung adenocarcinoma, gastric adenocarcinoma, chronic lymphocytic leukemia, ovarian cancer, etc.
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
